FindTrial
Sign In

Median effective dose of alfentanil combined with propofol inhibiting responses to laryngeal mask airway insertion in frail elderly patients

Median effective dose of alfentanil combined with propofol inhibiting responses to laryngeal mask airway insertion in frail elderly patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087142
Enrollment
Unknown
Registered
2024-07-22
Start date
2024-07-22
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and face skin tumor

Interventions

case senes:Alfentanil combined with propofol

Sponsors

Hangzhou Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Head and face skin tumor patients undergoing surgery 2.aged>65years, 3.Clinical Frailty Scale score =3

Exclusion criteria

Exclusion criteria: Upper respiratory tract infection within 2 weeks, asthma history.

Design outcomes

Primary

MeasureTime frame
LMA insertion responses;—

Secondary

MeasureTime frame
Mean arterial pressure;—

Countries

CHINA

Contacts

Public Contactwangbo

Hangzhou third peoples ’ hospital

qiubajia@163.com+86 150 6818 0821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026